Cullen/Frost Bankers, Inc. Emergent Bio Solutions Inc. Transaction History

Cullen/Frost Bankers, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$33.11 - $55.01 $9,337 - $15,512	-282 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$56.61 - $80.46 $164,112 - $233,253	-2,899 Reduced 91.13%	282 $18,000
Q1 2021 May 05, 2021	SELL	$86.23 - $125.19 $103,303 - $149,977	-1,198 Reduced 27.36%	3,181 $296,000
Q4 2020 Feb 08, 2021	BUY	$79.17 - $111.47 $114,796 - $161,631	1,450 Added 49.5%	4,379 $392,000
Q3 2020 Nov 05, 2020	BUY	$81.91 - $134.94 $44,313 - $73,002	541 Added 22.65%	2,929 $303,000
Q2 2020 Aug 05, 2020	BUY	$54.33 - $89.52 $129,740 - $213,773	2,388 New	2,388 $189,000

158

32.9M

424K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $462M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.